Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension

Published:2016-02-03 Issue:2 Volume:11 Page:e0142476
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Huang Wei-Chun,Ke Meng-Wei,Cheng Chin-Chang,Chiou Shih-Hwa,Wann Shue-Ren,Shu Chih-Wen,Chiou Kuan-Rau,Tseng Ching-Jiunn,Pan Hung-Wei,Mar Guang-Yuan,Liu Chun-Peng

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Cellular and molecular pathobiology of pulmonary arterial hypertension;M Humbert;J Am Coll Cardiol,2004

2. Endothelial dysfunction in pulmonary hypertension;R Budhiraja;Circulation,2004

3. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E;JD Smith;Proc Natl Acad Sci U S A,1995

4. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration;YY Zhao;J Clin Invest,2009

5. The monocrotaline model of pulmonary hypertension in perspective;JG Gomez-Arroyo;Am J Physiol Lung Cell Mol Physiol,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into the potential applications of stem cells in pulmonary hypertension therapy;Respiratory Research;2024-06-07

2. Unlocking the Future: Pluripotent Stem Cell-Based Lung Repair;Cells;2024-04-05

3. Exercise capacity-hemodynamics mismatch in elderly patients with pulmonary hypertension: A nationwide multicenter study from Taiwan Society of Cardiology Pulmonary Hypertension Registry (TAIPANS);Heliyon;2024-03

4. Induced pluripotent stem cell–derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1α and Runx2;Cardiovascular Research;2024-01

5. Stem cell therapy in pulmonary hypertension: current practice and future opportunities;European Respiratory Review;2023-09-27